Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An adaptive drug infusion system.

Meghan Simmons1, David Gillett, Brian Catanzaro

  • 1TheraFuse, Inc., Carlsbad, California 92008, USA.

Diabetes Technology & Therapeutics
|January 5, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus recommendations on lipohypertrophy: insights from an international panel of experts.

Diabetes research and clinical practice·2026
Same author

What do LLMs value? An evaluation framework for revealing subjective trade-offs in assessment of glycemic control.

Proceedings of machine learning research·2026
Same author

Real-World Evidence Assessment of the Risk of Nonfatal Stroke in Patients Prescribed SGLT2 Inhibitors.

Stroke research and treatment·2026
Same author

Pro-cognitive effects of 5-HT4 receptor agonism in individuals with remitted depression.

Psychological medicine·2026
Same author

Corrigendum to "Clinical assessment and acceptance criteria for continuous glucose monitoring (CGM) system performance: A proposed guideline by the IFCC working group on CGM" [Clin. Chim. Acta 580 (2026) 120728].

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

Continuous Glucose Monitoring and Mortality Risk Among U.S. Veterans Receiving Dialysis With Diabetes.

Diabetes care·2026
Same journal

Continuous Glucose Monitoring Metrics and Perinatal Outcomes in Pregnant Women with Type 2 Diabetes.

Diabetes technology & therapeutics·2026
Same journal

Invited Commentary: Using Large Clinical Databases.

Diabetes technology & therapeutics·2026
Same journal

Impact of Technology Introduction on Glycemic Control of People Living with Type 1 Diabetes in Belgium: An Observational, Real-World Study.

Diabetes technology & therapeutics·2026
Same journal

Differences in Achieving Stringent Glycemic Targets Among Youth with Type 1 Diabetes: A SWEET Registry Study.

Diabetes technology & therapeutics·2026
Same journal

<i>Letter:</i> "Nocturnal Hypoglycemia: Characterization with Continuous Glucose Monitoring in a Real-World Setting".

Diabetes technology & therapeutics·2026
Same journal

Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.

Diabetes technology & therapeutics·2026
See all related articles

This study introduces a miniature wearable drug infusion system using thermal time-of-flight technology for enhanced accuracy and reduced power consumption. Real-time compensation significantly improves therapeutic infusion performance.

Area of Science:

  • Biomedical Engineering
  • Medical Devices
  • Drug Delivery Systems

Background:

  • Ambulatory drug infusion systems require size and power reduction, alongside improved delivery accuracy, faster start-up, and quicker occlusion detection.
  • A novel non-contacting, low-power thermal time-of-flight technology was employed.
  • This technology enables a pressure-based miniature wearable drug infusion system with real-time compensation for pressure, viscosity, and flow path geometry variations.

Purpose of the Study:

  • To develop and evaluate a miniature wearable drug infusion system.
  • To demonstrate the benefits of real-time compensation for flow variables.

Main Methods:

  • Design and fabrication of prototype systems.
  • Bench testing and in-vivo animal testing (30-kg swine) were conducted.

Related Experiment Videos

Main Results:

  • Delivery accuracy and precision exceeded 1% for liquid volumes from 30 nL to 100 microL.
  • In-vivo tests on swine confirmed accurate drug delivery within study parameters.

Conclusions:

  • The developed prototypes showcase significant performance enhancements in therapeutic infusion.
  • Real-time compensation of flow variables is a key factor in achieving these improvements.